Results for tag: "Heart Defect Closure Device"

The Heart Defect Closure Device market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to close congenital heart defects, such as atrial septal defects (ASD) and ventricular septal defects (VSD). These devices are typically delivered to the heart via a catheter, and are designed to be minimally invasive. The devices are made of materials such as nitinol, polyester, and polypropylene, and are designed to be permanent. The Heart Defect Clclosure Device market is driven by the increasing prevalence of congenital heart defects, as well as the growing demand for minimally invasive treatments. The market is expected to grow in the coming years, as new technologies are developed and the demand for minimally invasive treatments continues to rise. Some companies in the Heart Defect Closure Device market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and W.L. Gore & Associates. Show Less Read more